Published in Am J Transl Res on November 15, 2016
Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med (2007) 16.95
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol (2014) 6.25
Another way to die: autophagic programmed cell death. Cell Death Differ (2005) 3.31
Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol (2009) 2.93
Myocardial protection by brief ischemia in noncardiac tissue. Circulation (1996) 2.91
Transient limb ischemia induces remote preconditioning and remote postconditioning in humans by a K(ATP)-channel dependent mechanism. Circulation (2007) 2.75
Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res (2007) 2.69
Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol (2012) 2.03
Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure. Cardiovasc Res (2006) 1.89
Programmed necrosis, not apoptosis, in the heart. Circ Res (2011) 1.64
Fibroblasts in myocardial infarction: a role in inflammation and repair. J Mol Cell Cardiol (2013) 1.61
The therapeutic potential of ischemic conditioning: an update. Nat Rev Cardiol (2011) 1.53
Postconditioning: reduction of reperfusion-induced injury. Cardiovasc Res (2006) 1.53
Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning. Am J Physiol Heart Circ Physiol (2006) 1.50
The innate immune response in reperfused myocardium. Cardiovasc Res (2012) 1.45
Panoramic imaging reveals basic mechanisms of induction and termination of ventricular tachycardia in rabbit heart with chronic infarction: implications for low-voltage cardioversion. Heart Rhythm (2008) 1.41
Targeting myocardial substrate metabolism in heart failure: potential for new therapies. Eur J Heart Fail (2012) 1.36
Ischemic preconditioning exaggerates cardiac damage in PKC-delta null mice. Am J Physiol Heart Circ Physiol (2004) 1.34
Acute myocardial infarction and heart failure: role of apoptosis. Int J Biochem Cell Biol (2006) 1.26
Ischemic preconditioning: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal (2008) 1.19
Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study. Catheter Cardiovasc Interv (2005) 1.08
Molecular adaptation of cellular defences following preconditioning of the heart by repeated ischaemia. Cardiovasc Res (1993) 1.05
Astragaloside IV prevents acute kidney injury in two rodent models by inhibiting oxidative stress and apoptosis pathways. Apoptosis (2013) 1.01
Combined local ischemic postconditioning and remote perconditioning recapitulate cardioprotective effects of local ischemic preconditioning. Am J Physiol Heart Circ Physiol (2010) 1.01
Repeated remote ischemic postconditioning protects against adverse left ventricular remodeling and improves survival in a rat model of myocardial infarction. Circ Res (2011) 1.00
Anti-hepatitis B virus activities of astragaloside IV isolated from radix Astragali. Biol Pharm Bull (2009) 0.99
Astragaloside IV protects heart from ischemia and reperfusion injury via energy regulation mechanisms. Microcirculation (2013) 0.92
Astragaloside IV stimulates angiogenesis and increases nitric oxide accumulation via JAK2/STAT3 and ERK1/2 pathway. Molecules (2013) 0.91
Repeated remote ischemic conditioning attenuates left ventricular remodeling via exosome-mediated intercellular communication on chronic heart failure after myocardial infarction. Int J Cardiol (2014) 0.90
Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy. Eur J Pharmacol (2011) 0.89
Angiotensin receptor blockers: current status and future prospects. Am J Med (2008) 0.88
The crossroads of inflammation, fibrosis, and arrhythmia following myocardial infarction. J Mol Cell Cardiol (2015) 0.87
Preconditioning prevents loss in mitochondrial function and release of cytochrome c during prolonged cardiac ischemia/reperfusion. Arch Biochem Biophys (2006) 0.85
The emerging role of Toll-like receptor 4 in myocardial inflammation. Cell Death Dis (2016) 0.84
Ischemic preconditioning produces more powerful anti-inflammatory and cardioprotective effects than limb remote ischemic postconditioning in rats with myocardial ischemia-reperfusion injury. Chin Med J (Engl) (2013) 0.83
Combination therapy with remote ischaemic conditioning and insulin or exenatide enhances infarct size limitation in pigs. Cardiovasc Res (2015) 0.81
Effects of acute and chronic atorvastatin on cardioprotection of ischemic postconditioning in isolated rat hearts. Cardiovasc Ther (2013) 0.81
Up-regulated TLR4 in cardiomyocytes exacerbates heart failure after long-term myocardial infarction. J Cell Mol Med (2015) 0.81
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences. World J Cardiol (2015) 0.80
The combination of L-arginine and ischaemic post-conditioning at the onset of reperfusion limits myocardial injury in the pig. Acta Physiol (Oxf) (2011) 0.80
Astragaloside IV prevents lipopolysaccharide-induced injury in H9C2 cardiomyocytes. Chin J Nat Med (2015) 0.80
Astragaloside IV suppresses transforming growth factor-β1 induced fibrosis of cultured mouse renal fibroblasts via inhibition of the MAPK and NF-κB signaling pathways. Biochem Biophys Res Commun (2015) 0.80
Anti-fibrotic effects of Astragaloside IV in systemic sclerosis. Cell Physiol Biochem (2014) 0.78
Astragaloside IV and cycloastragenol are equally effective in inhibition of endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation in the endothelium. J Ethnopharmacol (2015) 0.77
Therapeutic effect of astragaloside-IV on bradycardia is involved in up-regulating klotho expression. Life Sci (2015) 0.76
Astragaloside IV Inhibits the Inflammatory Injury of Chicken Type II Pneumocytes Induced by Avian Pathogenic Escherichia coli. Inflammation (2016) 0.76